HIV type 1 envelope subtype C sequences from recent seoconverters in Zimbabwe

AIDS Research and Human Retroviruses

Volumn 16, Issue 10, 2000, Pages 973-979

  Batra, Maneesh ^a   Tien, Phyllis C ^a   Shafer, Robert W ^a   Contag, Christopher H ^a   Katzenstein, David A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ARTICLE; CLINICAL ARTICLE; GENETIC DISTANCE; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROCONVERSION; SITE DIRECTED MUTAGENESIS; VIRUS ENVELOPE; VIRUS TRANSMISSION; ZIMBABWE;

AMINO ACID SEQUENCE; GENE PRODUCTS, ENV; GENES, ENV; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; VARIATION (GENETICS); ZIMBABWE;

EID: 0034235153     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050058399     Document Type: Article

References (40)

1. 1. Meyers G, Hahn BK, Jeang K, Mellors JW, McCutchan FE, Henderson LE, and Pavlakis GN: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico, 1995.
2. 2. Moore JP, Cao Y, Leu J, Qin L, Korber B, and Ho DD: Inter-and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. Virol 1999; 70:427-444.
3. 3. Soto-Ramirez LE, Tripathy S, Renjifo B, and Essex M: HIV-1 pol sequences from India fit distinct subtype pattern. AIDS 1996; 13:299-307.
4. 4. Lalvani A and Shastri JS: HIV epidemic in India: Opportunity to learn from the past. Lancet 1996;347:1349-1350.
5. 5. Tripathy S, Renjifo B, Wang WK, McLane MF, Bollinger R, Rodrigues J, Osterman J, Tripathy S, and Essex M: Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India. AIDS 1996;12:1199-1202.
6. 6. Jansson M, Orlandi P, Scarlatti G, Moschese V, Romiti ML, Cancrini C, Mancia L, Livadiotti S, Castelli-Gattinara G, Rossi P, and Halapi E: Role of immunity in maternal-infant HIV-1 transmission. Acta Paediatr Suppl 1997;421:39-45.
7. 7. Hu DJ, Dondero TJ, Rayfield MA, George JR, Schochetman G, Jaffe HW, Luo CC, Kalish ML, Weniger BG, Pau CP, Schable CA, and Curran JW: The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA 1996;275:210-216.
8. 8. Rübsamen-Waigmann H, von Briesen H, Holmes H, Bjorndal A, Korber B, Esser R, Ranjbar S, Tomlinson P, Galvao-Castro B, and Karita E: Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. WHO Network for HIV Isolation and Characterization. AIDS 1994;10: 1401-1408.
9. 9. Cheng-Mayer C, Seto D, Tateno M, and Levy JA: Biological features of HIV-1 that correlate with virulence in the host. Science 1988;240:80-82.
10. 10. Balachandran R, Thampatty P, Enrico A, Rinaldo C, and Gupta P: Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties. Virology 1991;180:229-238.
11. 11. Tersmette M, de Goede RE, Al BJ, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, and Miedema F: Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome AIDS and AIDS-related complex. J Virol 1988;62:2026-2032.
12. 12. Koot M, Keet IP, Vos AH, de Goede RE, Roos MT, Coutinho RA, Miedema F, Schellekens PT, and Tersmette M: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993;118: 681-688.
13. 13. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, and Ho DD: Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993;261:1179-1181.
14. 14. Zhu T, Wang N, Carr A, Nam DS, Moor-Jankowski R, Cooper DA, and Ho DD: Genetic charcterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996;70:3098-3107.
15. 15. Roos MT, Lange JM, de Goede RE, Coutinho RA, Schellekens PT, Miedema F, and Tersmette M: Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis 1992;165:427-432.
16. 16. Nielsen C, Pedersen C, Lundgren JD, and Gerstoft J: Biological properties of HIV isolates in primary HIF infection: Consequences for the subsequent course of infection. AIDS 1993;7:1035-1040.
17. 17. Freed EO and Risser R: Identification of conserved residues in the human immunodeficiency virus type 1 principal neutralizing determinant that are involved in fusion. AIDS 1991;7:807-811.
18. 18. Boyd MT, Simpson GR, Cann AJ, Johnson MA, and Weiss RA: A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J Virol 1993;67:3649-3652.
19. 19. Hwang SS, Boyle TJ, Lyerly HK, and Cullen BR: Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991;253:71-74.
20. 20. Groenink M, Fouchier RA, Broersen S, Baker CH, Koot M, van't Wout AB, Huisman HG, Miedema F, Tersmette M, and Schuitemaker H: Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 1993;260:1513-1516.
21. 21. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, and Landau NR: Identification of a major coreceptor for primary isolaes of HIV-1. Nature (London) 1996; 381:661-666.
22. 22. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, and Paxton WA: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 1996;381: 667-648.
23. 23. Tscherning C, Alaeus A, Fredriksson R, Bjorndal A, Deng H, Littman DR, Fenyö EM, and Albert J: Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998;241:181-188.
24. 24. Bjorndahl A, Sonnerborg A, Tscherning C, Albert J, and Fenyö EM: Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res Hum Retroviruses 1999;15:647-653.
25. 25. Abebe A, Demissie D, Goudsmit J, Brouwer M, Pollakis G, Fontanet A, and Rinke De Wit TF: Low frequency of HIV-1 subtype C syncytium inducing (SI) phenotype among Ethiopian AIDS patients. Int Conf AIDS 1998;12:1161. [Abstract 60879]
26. 26. Ping LH, Nelson JA, Hoffman I, Schock J, Fiscus S, Vernazza P, Kazemb P, Zimba D, Maida M, Cohen MS, and Swanstrom R: Genotypic analysis of subtype C HIV-1 suggests SI-like viruses are rare. In 5th Conference on Retroviruses and Opportunistic Infections, 1998, February 1-5, p. 185. [Abstract 556]
27. 27. Peeters M, Vincent R, Perret JL, Lasky M, Patrel D, Liegeois F, Courgnaud V, Seng R, Matton T, Molinier S, and Delaporte E: Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:115-121.
28. 28. Xiao L, Owen S, Goldman I, Lal A, deJong J, Goudsmit J, and Lal R: CCR5 coreceptor usage of nonsyncytium-inducing HIV-1 is independent of phylogenetically distinct global HIV-1 isolates; Delineation of consensus motif in the V3 domain that predicts CCR5 usage. Virology 1998;240:83-92.
29. 29. Tien PC, Chiu T, Winters M, Latif A, Ray S, Batra M, Contag CH, Moore D, Zejena L, Mbizvo M, Delwart EL, Mullins JI, and Katzenstein DA: Clinical and virologic characteristics of men recently infected with subtype C human immunodeficiency virus type 1 in Harare, Zimbabwe. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:147-153.
30. 30. Shafer RW, Eisen JA, Merigan TC, and Katzenstein DA: Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe. J Virol 1997;71:5441-5448.
31. 31. Shafer RW, Chaung T, Hsu P, White CB, and Katzenstein DA: Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. AIDS Res Human Retroviruses 1999;15:65-69.
32. 32. Delwart EL, Shpaer EG, Louwagie J, McCutchan FE, Grez M, Rübsamen-Waigmann H, and Mullins JI: Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 1993;262:1257-1261.
33. 33. Higgins DG, Bleasby AJ, and Fuchs R: CLUSTAL V: Improved software for multiple sequence alignment Comput Appl Biosci 1992;8:189-191.
34. 34. Felsenstein J: PHYLIP (Phylogeny Inference Package), version 3.5. University of Washington, Seattle, Washington, 1993.
35. 35. Korber B: Synonymous nonsynonymous analysis program. In: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic and Amino Acid Sequences. (Korber B, Hahn B, Foley B, Mellors JW, Leitner T, Myers G, McCutchan FE, and Kuiken CL, eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, 1998.
36. 36. National Center for Biotechnology Information: HIV-I Subtyping Tool (1998). www.ncbi.nlm.nih.gov/retroviruses/HIV 1
37. 37. Van Harmelan JH, van der Ryst E, Louber AS, York D, Madurai S, Lyons S, Wood R, and Williamson C: A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populations. AIDS Res Hum Retroviruses 1999;15:395-398.
38. 38. Englebrecht S, Smith T-L, Kasper P, Faatz E, Zeirer M, Moodley D, Clay CG, and van Rensberg EJ: HIV type 1 V3 domain serotyping and genotyping in Gauteng, Mpumalanga, Kwazulu-Natal and Western Cape provinces of South Africa. AIDS Res Hum Retroviruses 1999;15:325-328.
39. 39. Montano MA, Novitky VA, Blackard JT, Cho NL, Katzenstein DA, and Essex M: Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol 1997; 71:8657-8665.
40. 40. Johansson D, Sherefa K, and Sonnerborg A: Multiple enhancer motifs in HIV-1 type 1 strains from Ethiopia. AIDS Res Hum Retroviruses 1995;11:761-764.